Managing Comorbid Attention Deficit Hyperactivity Disorder (ADHD) in Adults With Substance Use Disorder (SUD): What the Addiction Specialist Needs to Know

被引:1
|
作者
Johnson, Joe [1 ]
Morris, Sarah [2 ]
George, Sanju [3 ]
机构
[1] Hollins Pk Hosp, North West Boroughs Partnership NHS Fdn Trust, North West Lead UKAAN UK Adult ADHD Network, NW Boroughs Adult ADHD Serv, Liverpool, Merseyside, England
[2] Hollins Pk Hosp, North West Boroughs Healthcare NHS Fdn Trust, Liverpool, Merseyside, England
[3] Rajagiri Coll Social Sci Autonomous, Rajagiri Sch Behav Sci & Res, Kochi 683104, Kerala, India
来源
ADDICTIVE DISORDERS & THEIR TREATMENT | 2021年 / 20卷 / 03期
关键词
attention deficit hyperactivity disorder; substance use disorder; comorbidity; management; DEFICIT/HYPERACTIVITY DISORDER; ALCOHOL; MANAGEMENT; SYMPTOMS;
D O I
10.1097/ADT.0000000000000237
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Attention deficit hyperactivity disorder (ADHD) and substance use disorder (SUD) often co-exist and the link between the 2 is bidirectional, with higher rates of ADHD symptoms found in the SUD population and higher rates of SUD found among the ADHD population. Some possible mechanisms which could explain the increased risk of developing a SUD in those who have ADHD include self-medication, both ADHD and SUD arising from dysregulation of 1 or more of the dopaminergic circuits, genetic factors as well exposure to parental SUD. Given the complex relationship between ADHD and SUD, those working in SUD services should be vigilant to ADHD as a possible comorbid diagnosis and refer to a specialist ADHD service for further assessment where appropriate. On the basis of a detailed clinical assessment, it has to be decided whether SUD or ADHD should be the priority for treatment or if they both ought to be; in either case, ADHD and SUD treatment services must work collaboratively. The recommended first line pharmacological treatment option for adolescents and adults with ADHD is a stimulant medication, with nonstimulants being reserved as a second or third line option. In the brief review paper, the authors further discuss the various medications for treatment of ADHD, the benefits and risks of treating ADHD in those with SUD, discuss the role of specialist ADHD treatment services, and illustrate these with the help of 2 anonymized case vignettes.
引用
收藏
页码:181 / 188
页数:8
相关论文
共 50 条
  • [21] Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults
    Castells, Xavier
    Blanco-Silvente, Lidia
    Cunill, Ruth
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (08):
  • [22] Attention deficit/hyperactivity disorder (ADHD) in adults Response
    Sitholey, P.
    Agarwal, V.
    Sharma, S.
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2009, 129 (04) : 459 - 460
  • [23] Bupropion for attention deficit hyperactivity disorder (ADHD) in adults
    Verbeeck, Wim
    Bekkering, Geertruida E.
    Van den Noortgate, Wim
    Kramers, Cornelis
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (10):
  • [25] What is attention-deficit hyperactivity disorder (ADHD)?
    Furman, L
    JOURNAL OF CHILD NEUROLOGY, 2005, 20 (12) : 994 - 1002
  • [26] Is substance use disorder with comorbid adult attention deficit hyperactivity disorder and bipolar disorder a distinct clinical phenotype?
    Ceraudo, Giuseppe
    Toni, Cristina
    Vannucchi, Giulia
    Rizzato, Salvatore
    Casalini, Francesca
    Dell'Osso, Liliana
    Maremmani, Icro
    Perugi, Giulio
    HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS, 2012, 14 (03) : 71 - 76
  • [27] Methylphenidate in Adults with Attention Deficit Hyperactivity Disorder and Substance Use Disorders
    Simon, Nicolas
    Rolland, Benjamin
    Karila, Laurent
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (23) : 3359 - 3366
  • [28] Coping styles in substance use disorder (SUD) patients with and without co-occurring attention deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD)
    Linda M. Kronenberg
    Peter J.J. Goossens
    Jooske van Busschbach
    Theo van Achterberg
    Wim van den Brink
    BMC Psychiatry, 15
  • [29] Personal Recovery in Individuals Diagnosed with Substance use Disorder (SUD) and Co-Occurring Attention Deficit/Hyperactivity Disorder (ADHD) or Autism Spectrum Disorder (ASD)
    Kronenberg, Linda M.
    Verkerk-Tamminga, Roeliene
    Goossens, Peter J. J.
    van den Brink, Wirn
    van Achterberg, Theo
    ARCHIVES OF PSYCHIATRIC NURSING, 2015, 29 (04) : 242 - 248
  • [30] Coping styles in substance use disorder (SUD) patients with and without co-occurring attention deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD)
    Kronenberg, Linda M.
    Goossens, Peter J. J.
    van Busschbach, Jooske
    van Achterberg, Theo
    van den Brink, Wim
    BMC PSYCHIATRY, 2015, 15